U.S. Markets closed
  • S&P 500

    3,699.12
    +32.40 (+0.88%)
     
  • Dow 30

    30,218.26
    +248.74 (+0.83%)
     
  • Nasdaq

    12,464.23
    +87.05 (+0.70%)
     
  • Russell 2000

    1,892.45
    +43.75 (+2.37%)
     
  • Crude Oil

    46.09
    +0.45 (+0.99%)
     
  • Gold

    1,837.70
    +0.90 (+0.05%)
     
  • Silver

    24.32
    +0.18 (+0.76%)
     
  • EUR/USD

    1.2127
    -0.0022 (-0.1819%)
     
  • 10-Yr Bond

    0.9690
    +0.0490 (+5.33%)
     
  • Vix

    20.79
    -0.49 (-2.30%)
     
  • GBP/USD

    1.3438
    -0.0015 (-0.1088%)
     
  • USD/JPY

    104.1400
    +0.2800 (+0.2696%)
     
  • BTC-USD

    19,143.24
    +94.95 (+0.50%)
     
  • CMC Crypto 200

    365.19
    -14.05 (-3.71%)
     
  • FTSE 100

    6,550.23
    +59.96 (+0.92%)
     
  • Nikkei 225

    26,751.24
    -58.13 (-0.22%)
     

SHAREHOLDER ALERT: Monteverde & Associates Continues to Investigate the Following Merger

·3 min read

NEW YORK, NY / ACCESSWIRE / November 20, 2020 / Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating:

  • Navistar International Corporation (NYSE:NAV) relating to its proposed acquisition by TRATON SE, Inc. Under the terms of the agreement, Navistar shareholders will receive $44.50 per share in cash. Click here for more information: https://www.monteverdelaw.com/case/navistar-international-corporation. It is free and there is no cost or obligation to you.

  • PNM Resources, Inc. (NYSE:PNM) relating to its proposed acquisition by Avangrid, Inc. Under the terms of the agreement, PNM shareholders will receive $50.30 per share in cash. Click here for more information: http://monteverdelaw.com/case/pnm-resources-inc. It is free and there is no cost or obligation to you.

  • Eidos Therapeutics, Inc. (NASDAQ:EIDX) relating to its proposed acquisition by BridgeBio Pharma, Inc. ("BridgeBio"). Under the terms of the agreement, Eidos' shareholders will receive 1.85 shares of BridgeBio common stock or $73.26 in cash per share. Click here for more information: https://www.monteverdelaw.com/case/eidos-therapeutics-inc. It is free and there is no cost or obligation to you.

About Monteverde & Associates PC
We are a national class action securities litigation law firm that has recovered millions of dollars and is committed to protecting shareholders from corporate wrongdoing. Our lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions. Mr. Monteverde is recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013, 2017-2019, an award given to less than 2.5% of attorneys in a particular field. He has also been selected by Martindale-Hubbell as a 2017-2019 Top Rated Lawyer. Our firm's recent successes include changing the law in a significant victory that lowered the standard of liability under Section 14(e) of the Exchange Act in the Ninth Circuit. Thereafter, our firm successfully preserved this victory by obtaining dismissal of a writ of certiorari as improvidently granted at the United States Supreme Court. Emulex Corp. v. Varjabedian, 139 S. Ct. 1407 (2019). Also, in 2019 we recovered or secured six cash common funds for shareholders in mergers & acquisitions class action cases.

If you own common stock in any of the above listed companies and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341.

Contact:
Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4405
New York, NY 10118
United States of America
jmonteverde@monteverdelaw.com
Tel: (212) 971-1341

Attorney Advertising. (C) 2020 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.

SOURCE: Monteverde & Associates PC.



View source version on accesswire.com:
https://www.accesswire.com/617809/SHAREHOLDER-ALERT-Monteverde-Associates-Continues-to-Investigate-the-Following-Merger